327 related articles for article (PubMed ID: 36778126)
21. Nanotechnology lights up the antitumor potency by combining chemotherapy with siRNA.
Sun J; Ogunnaike EA; Jiang X; Chen Z
J Mater Chem B; 2021 Sep; 9(36):7302-7317. PubMed ID: 34382987
[TBL] [Abstract][Full Text] [Related]
22. Engineering DNA scaffolds for delivery of anticancer therapeutics.
Sun W; Gu Z
Biomater Sci; 2015 Jul; 3(7):1018-24. PubMed ID: 26221936
[TBL] [Abstract][Full Text] [Related]
23. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
Markovsky E; Baabur-Cohen H; Satchi-Fainaro R
J Control Release; 2014 Aug; 187():145-57. PubMed ID: 24862318
[TBL] [Abstract][Full Text] [Related]
24. Nucleic acid-based drugs for patients with solid tumours.
Huayamares SG; Loughrey D; Kim H; Dahlman JE; Sorscher EJ
Nat Rev Clin Oncol; 2024 Jun; 21(6):407-427. PubMed ID: 38589512
[TBL] [Abstract][Full Text] [Related]
25. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
26. The importance of co-delivery of nanoparticle-siRNA and anticancer agents in cancer therapy.
Khelghati N; Soleimanpour Mokhtarvand J; Mir M; Alemi F; Asemi Z; Sadeghpour A; Maleki M; Samadi Kafil H; Jadidi-Niaragh F; Majidinia M; Yousefi B
Chem Biol Drug Des; 2021 Apr; 97(4):997-1015. PubMed ID: 33458952
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
Li Y; Hou H; Zhang P; Zhang Z
Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
[TBL] [Abstract][Full Text] [Related]
28. Nucleic acid drug vectors for diagnosis and treatment of brain diseases.
Lu ZG; Shen J; Yang J; Wang JW; Zhao RC; Zhang TL; Guo J; Zhang X
Signal Transduct Target Ther; 2023 Jan; 8(1):39. PubMed ID: 36650130
[TBL] [Abstract][Full Text] [Related]
29. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
Shen S; Liu M; Li T; Lin S; Mo R
Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
[TBL] [Abstract][Full Text] [Related]
30. Amphiphilic siRNA Conjugates for Co-Delivery of Nucleic Acids and Hydrophobic Drugs.
Lee SH; Lee JY; Kim JS; Park TG; Mok H
Bioconjug Chem; 2017 Aug; 28(8):2051-2061. PubMed ID: 28671455
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
32. Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.
Shah V; Taratula O; Garbuzenko OB; Taratula OR; Rodriguez-Rodriguez L; Minko T
Clin Cancer Res; 2013 Nov; 19(22):6193-204. PubMed ID: 24036854
[TBL] [Abstract][Full Text] [Related]
33. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.
Fattal E; Fay F
Adv Drug Deliv Rev; 2021 Aug; 175():113809. PubMed ID: 34033819
[TBL] [Abstract][Full Text] [Related]
34. Nucleic Acid Bioconjugates in Cancer Detection and Therapy.
Patel PL; Rana NK; Patel MR; Kozuch SD; Sabatino D
ChemMedChem; 2016 Feb; 11(3):252-69. PubMed ID: 26663095
[TBL] [Abstract][Full Text] [Related]
35. Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy.
Fumoto S; Nishida K
Chem Pharm Bull (Tokyo); 2020; 68(7):603-612. PubMed ID: 32611997
[TBL] [Abstract][Full Text] [Related]
36. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
37. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
38. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
39. Promise of chemokine network-targeted nanoparticles in combination nucleic acid therapies of metastatic cancer.
Xie Y; Wang Y; Li J; Hang Y; Oupický D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1528. PubMed ID: 29700990
[TBL] [Abstract][Full Text] [Related]
40. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
Cadete A; Alonso MJ
Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
